Thus, therapeutic strategies to boost CHCHD10 and/or PINK1 levels or activity could provide simultaneous protection against the accumulation of TDP-43 and defective clearance of dysfunctional mitochondria in ALS-FTD. This evidence concerns the gene TARDBP and frontotemporal dementia.